Ansbert Gadicke - Director, 10%+ Owner at Kalaris Therapeutics, Inc.

Issuer-level insider activity

Role
Director, 10%+ Owner
Issuer ticker
KLRS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Ansbert Gadicke since 22 Aug 2025

Reported holdings for Ansbert Gadicke in Kalaris Therapeutics, Inc.

Form 4 holding Director, 10%+ Owner

Allovir, Inc.

Security class
Common Stock
Shares / value
16,674,766
Estimated value
$11,185,433
Report date
28 Jul 2022
Price
$0.6708
Ownership
By ElevateBio LLC
Form 4 holding Director, 10%+ Owner

Allovir, Inc.

Security class
Common Stock
Shares / value
30,197
Estimated value
$20,256
Report date
28 Jul 2022
Price
$0.6708
Ownership
Direct

Transaction history for Ansbert Gadicke in Kalaris Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .